BiotechTube
Home/LB Pharmaceuticals/Anna Eramo, M.D.
AE

Anna Eramo, M.D.

Chief Medical Officer

LB Pharmaceuticals

Therapeutic Areas

SchizophreniaBipolar DepressionNeuropsychiatric Diseases

LB Pharmaceuticals Pipeline

DrugIndicationPhase
LB-102SchizophreniaPhase 2

Leadership Team at LB Pharmaceuticals

HT
Heather Turner, J.D.
Chief Executive Officer and Director
KP
Kaya Pai Panandiker
Chief Commercial Officer
GS
Gad Soffer
Chief Business Officer
MP
Minako Pazdera, J.D., Ph.D.
General Counsel
LB
Lindsay Beaupre
Senior Vice President, People and Culture
MP
Marc Panoff
Senior Vice President, Finance
JR
James Rawls, Pharm.D.
Senior Vice President, Regulatory Affairs
ER
Ellen Rose
Senior Vice President, Corporate Affairs
RA
Richard A. Silva, Ph.D.
Senior Vice President, Technical Operations
JM
John M. Kane, M.D.
Chairman, Scientific Advisory Board
View full LB Pharmaceuticals profile